This document may not be distributed, directly or indirectly, in the United States of America, Canada, Australia or Japan. Result of capital increase with preferential subscription rights in a gross
This document may not be distributed, directly or indirectly, in the United States of America, Canada, Australia or Japan. Global Bioenergies launches €7.5 million capital increase with. | March 6, 2023
Global Bioenergies: First significant sales in 2022 Start of commercial production and sales of €0.7m Gross cash position of €8.8m at 31 December 2022 CSR
Global Bioenergies: First significant sales in 2022 Start of commercial production and sales of €0.7m Gross cash position of €8.8m at 31 December 2022 CSR maturity score of 56/100